Jade Biosciences (JBIO) Interest Expenses (2021 - 2024)
Jade Biosciences (JBIO) reported Interest Expenses of $6000.0 for Q2 2024, up 500.0% on a YoY basis from $1000.0 in Q3 2023, and up 100.0% quarter-over-quarter from $3000.0 in Q1 2024.
Jade Biosciences (JBIO) Interest Expenses (2021 - 2024) Analysis & Trends
Jade Biosciences has reported Interest Expenses for 4 years, with the latest figure at $6000.0 in Q2 2024.
- For the quarter ending Q2 2024, Interest Expenses rose 500.0% year-over-year to $6000.0; the trailing twelve-month figure through Mar 2025 stood at $6000.0 (up 50.0% YoY), and the FY2023 full-year result was $1000.0, down 98.73% from the prior year.
- Interest Expenses for Q2 2024 stood at $6000.0, up from $3000.0 in the prior quarter.
- The five-year high for Interest Expenses was $6000.0 in Q2 2022, with the low at -$1000.0 in Q4 2021.
- Historically, Interest Expenses has averaged $2500.0 across 4 years, with a median of $2000.0 in 2021.
- Annual changes were most pronounced in 2023 — Interest Expenses tumbled 83.33% — and 2024, when it soared 500.0%.
- Jade Biosciences' Interest Expenses stood at -$1000.0 in 2021, then jumped by 700.0% to $6000.0 in 2022, then plunged by 83.33% to $1000.0 in 2023, then soared by 500.0% to $6000.0 in 2024.
- The last three Interest Expenses figures came in at $6000.0 (Q2 2024), $3000.0 (Q1 2024), and $1000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Jade Biosciences | 973.55 Mn | 973.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |